Review
Leber’s hereditary optic neuropathy: research progress and novel views of prevention and treatment
Su Xun, Zhang Zhikang, Ji Dongmei, Cao Yunxia
Published 2022-12-15
Cite as Int J Genet, 2022, 45(6): 448-455. DOI: 10.3760/cma.j.cn231536-20220718-00069
Abstract
Leber hereditary optic neuropathy (LHON) is one of the most common mitochondrial diseases mainly caused by mitochondrial DNA mutations and which usually cause rapid and painless onset of loss of bilateral vision. Effective treatments and preventions are not available. More than 150 years after LHON was first reported, and more than 30 years after discovering LHON associated with mtDNA mutations, we still not make a major breakthrough on the research, mainly hampered by the lack of appropriate models. This paper mainly focuses on the latest research results of LHON and the new progress of disease prevention and treatment, aiming to further strengthen the understanding of this disease.
Key words:
Leber hereditary optic neuropathy; mtDNA; Human induced pluripotent stem cell; Treatment
Contributor Information
Su Xun
Reproductive Medicine Center, Department of Obstetrics and Gynecology, the First Affiliated Hospital of Anhui Medical University, Hefei 230022, China
Zhang Zhikang
Reproductive Medicine Center, Department of Obstetrics and Gynecology, the First Affiliated Hospital of Anhui Medical University, Hefei 230022, China
Ji Dongmei
Reproductive Medicine Center, Department of Obstetrics and Gynecology, the First Affiliated Hospital of Anhui Medical University, Hefei 230022, China
Cao Yunxia
Reproductive Medicine Center, Department of Obstetrics and Gynecology, the First Affiliated Hospital of Anhui Medical University, Hefei 230022, China